Bcl-2 protein is strongly expressed in post-transplant lymphoproliferative disorders

Journal of Pathology

Volumn 180, Issue 3, 1996, Pages 254-258

  Chetty, Runjan ^a,d   Biddolph, Simon ^b   Kaklamanis, Loukas ^a   Cary, Nat ^c   Stewart, Susan ^c   Giatromanolaki, Alexandra ^a   Gatter, Kevin ^a  

^a UNIVERSITY OF OXFORD   (United Kingdom)

^b JOHN RADCLIFFE HOSPITAL   (United Kingdom)

^c PAPWORTH HOSPITAL   (United Kingdom)

^d UNIVERSITY OF NATAL   (South Africa)

Author keywords

bcl 2; EBV; p53; Post transplant lymphoproliferative disorders

Indexed keywords

PROTEIN BCL 2; PROTEIN P53;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; EPSTEIN BARR VIRUS; FEMALE; HEART TRANSPLANTATION; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; KIDNEY TRANSPLANTATION; LUNG TRANSPLANTATION; LYMPHOPROLIFERATIVE DISEASE; MALE; ORGAN TRANSPLANTATION; PRIORITY JOURNAL;

ADULT; AGED; FEMALE; HEART TRANSPLANTATION; HEART-LUNG TRANSPLANTATION; HERPESVIRIDAE INFECTIONS; HERPESVIRUS 4, HUMAN; HUMANS; IMMUNOCOMPROMISED HOST; KIDNEY TRANSPLANTATION; LYMPHOPROLIFERATIVE DISORDERS; MALE; MIDDLE AGED; ORGAN TRANSPLANTATION; POSTOPERATIVE COMPLICATIONS; PROTO-ONCOGENE PROTEINS C-BCL-2; TUMOR SUPPRESSOR PROTEIN P53; TUMOR VIRUS INFECTIONS; VIRAL MATRIX PROTEINS;

EID: 0029844368     PISSN: 00223417     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1096-9896(199611)180:3<254::AID-PATH671>3.0.CO;2-D     Document Type: Article

References (20)

1. Henderson S, Rowe M, Gregory C, et al. Induction of bcl-2 expression by Epstein-Barr virus latent membrane protein I protects infected B cells from programmed cell death. Cell 1991; 65: 1107-1115.
2. Armstrong AA, Gallgher A, Krajewski AS, et al. The expression of EBV latent membrane protein (LMP-1) is independent of CD23 and bcl-2 in Reed-Sternberg cells in Hodgkin's disease. Histopathology 1992; 21: 72-73.
3. Khan G, Gupta RK, Coates PJ, Slavin G. Epstein-Barr virus infection and bcl-2 proto-oncogene expression. Separate events in the pathogenesis of Hodgkin's disease? Am J Pathol 1993; 143: 1270-1274.
4. Bhagat SKM, Medeiros LJ, Weiss LM, et al. bcl-2 expression in Hodgkin's disease. Correlation with the t(14;18) translocation and Epstein-Barr virus. Am J Clin Pathol 1993; 99: 604-608.
5. Khan G, Coates PJ. The role of Epstein-Barr virus in the pathogenesis of Hodgkin's disease. J Pathol 1994; 174: 141-149.
6. Nalesnik M, Jaffe R, Starzl TE, et al. The pathology of posttransplant lymphoproliferative disorders occurring in the setting of cyctosporine A-prednisone immunosuppression. Am J Pathol 1988; 133: 173-192.
7. Hanto DW, Gajl-Peczalska KJ, Frizzera G, et al. Epstein-Barr virus (EBV) induced polyclonal and monoclonal B-cell lymphoproliferative diseases occurring after renal transplantation. Ann Surg 1983; 198: 356-368.
8. Nalesnik MA, Makowka L, Starzl TE. The diagnosis and treatment of post-transplant lymphoproliferative disorders. Curr Probl Surg 1988; 25: 365-472.
9. Ferry JA, Harris NL. Lymphoproliferative disorders following organ transplantation. Adv Pathol Lab Med 1994; 7: 359-387.
10. Borisch B, Hennig I, Horber F, Burki K, Laissue J. Enteropathy-associated T-cell lymphoma in a renal transplant patient with evidence of Epstein-Barr virus involvement. Virchows Arch 1992; 421: 443-447.
11. Kumar S, Kumar D, Kingma DW, Jaffe ES. Epstein-Barr virus associated T-cell lymphoma in a renal transplant patient. Am J Surg Pathol 1993; 17: 1046-1053.
12. D'Amore ESG, Manivel JC, Gajl-Peczalska KJ, et al. B-cell lymphoproliferative disorders after bone marrow transplant. An analysis of ten cases with emphasis on Epstein-Barr virus detection by in situ hybridisation. Cancer 1991; 68: 1285-1295.
13. Bird AG, McLachlan SM, Britton S. Cyclosporin A promotes spontaneous outgrowth in vitro of Epstein-Barr virus-induced B-cell lines. Nature 1981; 289: 300-301.
14. Miller G. In: Fields BN, ed. Epstein-Barr Virus: Biology, Pathogenesis and Medical Aspects. Virology. New York: Raven Press, 1990; 1921-1958.
15. Gregory CD, Dive C, Henderson S, et al. Activation of Epstein-Barr latent genes protects human B cells from death by apoptosis. Nature 1991; 349: 612-614.
16. Kouvidou Ch, Kanavaros P, Papaloannou D, et al. Expression of bcl-2 and p53 proteins in nasopharyngeal carcinoma. Absence of correlation with the presence of EBV encoded EBER 1-2 transcripts and latent membrane protein-1. J Clin Pathol: Mol Pathol 1995; 48: M17-M22.
17. Schlaifer D, Brousset P, Attal M, et al. bcl-2 proto-oncogene and Epstein-Barr virus latent membrane protein-1 expression in AIDS-related lymphoma. Histopathology 1994; 25: 77-82.
18. Rowe M, Peng-Pilon M, Huen DS, et al. Upregulation of bcl-2 by the Epstein-Bar virus latent membrane protein LMP-1: a B-cell-specific response that is delayed relative to NK-κB activation and to induction of cell surface markers. J Virol 1994; 68: 5602-5612.
19. Pezzella F, Morrison H, Jones M, et al. Immunohistochemical detection of p53 and bcl-2 proteins in non-Hodgkin's lymphoma. Histopathology 1993; 22: 39-44.
20. Ryan JJ, Prochownik E, Gottlieb Ca, et al. c-myc and bcl-2 modulate p53 function by altering p53 subcellular trafficking during the cell cycle. Proc Natl Acad Sci USA 1994; 91: 5878-5882.